“…301 In order to better exploit the generally assumed benefits of organocatalysis (lower catalyst cost and toxicity), the application of ubiquitous biobased compounds such as amino acids, 302,303 peptides, [304][305][306] sugars, 307 and vitamins, 308 would be highly attractive. 309 In this context, L-ascorbic acid (14), a well-established biobased HBD for the cycloaddition of heterocumulenes to epoxides under ambient or mild conditions, 310,311 was applied in combination with TBAC for the cycloaddition of CO 2 to iEFAs. 231 Ascorbic acid was found to accelerate the quaternary ammonium salt-catalyzed cycloaddition of CO 2 to iEFA1, with the binary combination 14/TBAC showing the best performance in terms of iCFA1 selectivity (see also Table 3).…”